Search

Organic single crystals are highly promising for applications in optoelectronic devices because of their higher mobility and thermal stability than amorphous thin films. Although white organic single crystals have been fabricated by the double-doped method and applied to realize white organic light‐emitting devices (WOLEDs), the unbalanced carrier transport properties of the unipolar crystals severely limit the device performance. Here, ambipolar white organic single crystals are obtained by using mixed p- and n-type molecules as an ambipolar host for the red and green dopants. The white crystal with balanced carrier transport and balanced blue, green, and red emission intensity was applied to the single-crystal WOLEDs. The highest brightness of 1956 cd m−2 and the current efficiency of 1.31 cd A−1 are achieved, which are the best performance of the single-crystal WOLEDs reported to date. A high color rendering index is obtained, which varies between 82 and 87 with increasing driving current. It is expectable that this strategy would support the practical applications of organic single crystal-based OLEDs. [ABSTRACT FROM AUTHOR]

Carrier mobility is one of the key issues for applications of organic semiconductors in electronic and optoelectronic devices. Organic single crystals possess much higher carrier mobility compared to amorphous films. However, unipolar properties with unbalanced hole and electron transporting ability have been a bottleneck for the high performance of organic single crystal‐based devices. Here, well‐balanced ambipolar organic single crystals are developed by mixing of n‐ and p‐type molecules with maintained single‐crystalline structures. Carrier mobility of the ambipolar single crystals is manipulated by tuning the mixing ratio, and nearly equal hole and electron mobility can be achieved. Highly efficient single crystal‐based organic light‐emitting devices (OLEDs) are demonstrated by employing the ambipolar crystals as the mixed host for a red emitter pentacene to realize efficient exciton confinement and energy transfer within the emissive layer. As a result, maximum luminance of 5467 cd m−2 and current efficiency of 2.82 cd A−1 are achieved, which represents, to the best of the authors' knowledge, the record performance for the organic single crystal‐based OLEDs to date. The strategy to manipulate the charge‐transport properties of the organic single crystals in this work represents a significant step toward practical applications of the organic single crystals in optoelectronics. [ABSTRACT FROM AUTHOR]

Aim:Gelsemine, an alkaloid from the Chinese herb Gelsemium elegans (Gardn & Champ) Benth., is effective in mitigating chronic pain in rats. In the present study we investigated whether the alkaloid improved sleep disturbance, the most common comorbid symptoms of chronic pain, in a mouse model of neuropathic pain.Methods:Mice were subjected to partial sciatic nerve ligation (PSNL). After the mice were injected with gelsemine or pregabalin (the positive control) intraperitoneally, mechanical allodynia and thermal hyperalgesia were assessed, and electroencephalogram (EEG)/electromyogram (EMG) recording was performed. Motor performance of the mice was assessed using rota-rod test. c-Fos expression in the brain was analyzed with immunohistochemical staining.Results:In PSNL mice, gelsemine (2 and 4 mg/kg) increased the mechanical threshold for 4 h and prolonged the thermal latencies for 3 h. Furthermore, gelsemine (4 mg/kg, administered at 6:30 AM) increased non-rapid eye movement (non-REM, NREM) sleep, decreased wakefulness, but did not affect REM sleep during the first 3 h in PSNL mice. Sleep architecture analysis showed that gelsemine decreased the mean duration of wakefulness and increased the total number of episodes of NREM sleep during the first 3 h after the dosing. Gelsemine (4 mg/kg) did not impair motor coordination in PSNL mice. Immunohistochemical study showed that PSNL increased c-Fos expression in the neurons of the anterior cingulate cortex, and gelsemine (4 mg/kg) decreased c-Fos expression by 58%. Gelsemine (4 mg/kg, administered at either 6:30 AM or 8:30 PM) did not produce hypnotic effect in normal mice. Pregabalin produced similar antinociceptive and hypnotic effects, but impaired motor coordination in PSNL mice.Conclusion:Gelsemine is an effective agent for treatment of both neuropathic pain and sleep disturbance in PSNL mice; anterior cingulate cortex might play a role in the hypnotic effects of gelsemine. [ABSTRACT FROM AUTHOR]